ondansetron has been researched along with Amphetamine Abuse in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ondansetron was well tolerated and was less likely than placebo to be associated with serious adverse events." | 2.73 | A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. ( Ait-Daoud, N; Bloch, DA; Elkashef, AM; Johnson, BA; Kahn, R; Li, SH; Smith, EV; Vocci, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, BA | 1 |
| Ait-Daoud, N | 1 |
| Elkashef, AM | 1 |
| Smith, EV | 1 |
| Kahn, R | 1 |
| Vocci, F | 1 |
| Li, SH | 1 |
| Bloch, DA | 1 |
1 trial available for ondansetron and Amphetamine Abuse
| Article | Year |
|---|---|
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognitive Behav | 2008 |